Castle Biosciences, Inc. (CSTL)

29.86 +0.92 (+3.18%) USD  |  NASDAQ  |  Feb 24, 12:54
More

Castle Biosciences Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for CSTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Delcath Systems, Inc. Upgrade
CorMedix, Inc. Upgrade
CytoSorbents Corp. Upgrade
Odyssey Health, Inc. Upgrade